Ramakrishnan Arul

Title: Ramakrishnan Arul: Innovator in Pharmaceutical Chemistry

Introduction

Ramakrishnan Arul is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of clopidogrel, a widely used platelet aggregation inhibitor.

Latest Patents

Ramakrishnan Arul holds a patent for "Crystalline polymorphs of clopidogrel." This invention relates to novel crystalline forms of clopidogrel in the form of hydrogen bromide salts, identified as polymorph forms 1, 2, and 3. The patent also covers processes for preparing these forms, pharmaceutical compositions comprising them, and their uses in treating various cardiovascular disorders. These compositions are particularly useful for inhibiting platelet aggregation and managing conditions such as thrombosis, atherothrombosis, ischemic stroke, and unstable angina.

Career Highlights

Throughout his career, Ramakrishnan has worked with prominent companies in the pharmaceutical sector, including Generics (UK) Limited and Generics Limited. His expertise in pharmaceutical formulations has contributed to advancements in drug development and delivery.

Collaborations

Ramakrishnan has collaborated with several professionals in his field, including Ajay Singh Rawat and Maheshkumar Gadakar. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Ramakrishnan Arul's work in developing crystalline forms of clopidogrel showcases his innovative spirit and dedication to improving healthcare solutions. His contributions to pharmaceutical chemistry are significant and continue to impact the industry positively.